Continuous, real-time and in situ measurement of biomolecule levels from blood or tissue fluids offers the potential to accelerate our understanding of fundamental physiological and pathological processes, to monitor drug metabolism, and to develop new therapies that utilise live biochemical information to guide treatment. Current point-of-care detection technologies are only able to perform one time measurement, which may miss out vital information, bring to wrong diagnostics and poor treatment.
We envisage that our device can be used in intensive care situations where accurate and real-time monitoring is desirable for rapid clinical responses, or be employed for therapeutic drug monitoring, new drug development and scientific research. The device can also become an integral part of a future generation of smart sensor networks when combined with other sensor technologies. In this way a wide spectrum of biochemical and physical data could be measured simultaneously and cross-correlated, which would be instrumental in the future development of precision medicine, personalised healthcare and homecare.
Stay up to date on the latest news in health and environmental practices.
We cover the latest stories from research and development to staying informed on the latest technologies.